Skip to main content

Table 1 Baseline measure scores for women who consented to randomisation

From: Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study

Measure (minimum, maximum possible scores)

N

Mean

Standard deviation

Median

Range

STAI Trait (20, 80)

174

35.2

9.9

34.0

20–64

State (20, 80)

175

37.7

11.8

37.0

20–68

EQ-5D VAS (0, 100)

176

83.1

14.6

85.0

20–100

SF36-v2 PCS (0, 100)

174

52.7

8.7

55.7

20.3–68.9

MCS (0, 100)

174

50.2

9.6

52.4

23.2–67.6